抗原-话题@MedSci

#抗原#

244篇内容 | 4306人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1623443, encodeId=6c2b1623443bc, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Nature：一类新型抗原呈递细胞在生命早期建立肠道免疫耐受, objectType=article, longId=739157, objectId=c327e3915725, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c327e3915725, replyNumber=0, likeNumber=109, createdTime=2022-09-14, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c327e3915725, moduleTitle=Nature：一类新型抗原呈递细胞在生命早期建立肠道免疫耐受, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c327e3915725)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623442, encodeId=a46d1623442b2, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=J Autoimmun：磷酸酶控制细胞因子介导的半乳糖缺陷型IgA1（IgA肾病的主要自身抗原）过量产生, objectType=article, longId=737608, objectId=3d6ce37608a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d6ce37608a5, replyNumber=0, likeNumber=104, createdTime=2022-09-03, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d6ce37608a5, moduleTitle=J Autoimmun：磷酸酶控制细胞因子介导的半乳糖缺陷型IgA1（IgA肾病的主要自身抗原）过量产生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d6ce37608a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623440, encodeId=c05e16234408f, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Clin Infect Dis：南非晚期HIV疾病队列中抗体免疫与隐球菌抗原血症和死亡率的关系, objectType=article, longId=737350, objectId=07a6e373508f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=07a6e373508f, replyNumber=0, likeNumber=111, createdTime=2022-08-31, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=07a6e373508f, moduleTitle=Clin Infect Dis：南非晚期HIV疾病队列中抗体免疫与隐球菌抗原血症和死亡率的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=07a6e373508f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623439, encodeId=c25f1623439bd, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle= Cancer Cell：BioNTech新论文——肿瘤新抗原疫苗+化疗+PD-1，三管齐下治肺癌, objectType=article, longId=737316, objectId=0e77e37316b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e77e37316b6, replyNumber=0, likeNumber=114, createdTime=2022-08-31, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e77e37316b6, moduleTitle= Cancer Cell：BioNTech新论文——肿瘤新抗原疫苗+化疗+PD-1，三管齐下治肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e77e37316b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623438, encodeId=dcac1623438e0, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Eur Urol：前列腺特异性膜抗原放射引导手术检测前列腺癌患者的淋巴结转移, objectType=article, longId=736957, objectId=bbe4e36957f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bbe4e36957f4, replyNumber=0, likeNumber=104, createdTime=2022-08-27, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bbe4e36957f4, moduleTitle=Eur Urol：前列腺特异性膜抗原放射引导手术检测前列腺癌患者的淋巴结转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bbe4e36957f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623437, encodeId=2841162343e75, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Rh抗原分型出现双群的原因解析和案例分享, objectType=article, longId=736613, objectId=03c7e3661338, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=03c7e3661338, replyNumber=0, likeNumber=89, createdTime=2022-08-24, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=03c7e3661338, moduleTitle=Rh抗原分型出现双群的原因解析和案例分享, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=03c7e3661338)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623436, encodeId=18d4162343654, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=JAMA netw open：人类白细胞抗原和其他位点单核苷酸变异与儿童霍奇金淋巴瘤的关系, objectType=article, longId=735362, objectId=69b5e3536288, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69b5e3536288, replyNumber=0, likeNumber=107, createdTime=2022-08-11, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69b5e3536288, moduleTitle=JAMA netw open：人类白细胞抗原和其他位点单核苷酸变异与儿童霍奇金淋巴瘤的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=69b5e3536288)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623435, encodeId=1cea1623435ec, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=肿瘤抗原诱导的T细胞耗竭：免疫“热”肿瘤的大敌, objectType=article, longId=733652, objectId=7be9e33652a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7be9e33652a6, replyNumber=0, likeNumber=100, createdTime=2022-07-30, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7be9e33652a6, moduleTitle=肿瘤抗原诱导的T细胞耗竭：免疫“热”肿瘤的大敌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7be9e33652a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623434, encodeId=d1a316234343c, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Front Immunol：HBV感染肝癌患者接受PD-1抑制剂联合治疗时HBV DNA和乙肝表面抗原水平与肿瘤疗效、肝功能和免疫学指标的相关性, objectType=article, longId=730662, objectId=e010e3066291, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e010e3066291, replyNumber=0, likeNumber=97, createdTime=2022-06-29, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e010e3066291, moduleTitle=Front Immunol：HBV感染肝癌患者接受PD-1抑制剂联合治疗时HBV DNA和乙肝表面抗原水平与肿瘤疗效、肝功能和免疫学指标的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e010e3066291)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623433, encodeId=f78f1623433c6, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Eur Urol：前列腺特异性膜抗原放射引导进行挽救性淋巴结清扫治疗患者的肿瘤学结果, objectType=article, longId=730533, objectId=3dfde3053389, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3dfde3053389, replyNumber=0, likeNumber=93, createdTime=2022-06-28, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3dfde3053389, moduleTitle=Eur Urol：前列腺特异性膜抗原放射引导进行挽救性淋巴结清扫治疗患者的肿瘤学结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3dfde3053389)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623432, encodeId=791e162343201, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Exp Hematol：血清 B 细胞成熟抗原是未经治疗的慢性淋巴细胞白血病的独立预后标志物 , objectType=article, longId=728558, objectId=0b3be2855881, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b3be2855881, replyNumber=0, likeNumber=85, createdTime=2022-06-04, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b3be2855881, moduleTitle=Exp Hematol：血清 B 细胞成熟抗原是未经治疗的慢性淋巴细胞白血病的独立预后标志物 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b3be2855881)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623429, encodeId=de351623429c5, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=Lancet子刊：不明原因儿童急性肝炎或与新冠病毒超级抗原及腺病毒41F叠加相关, objectType=article, longId=727054, objectId=79f3e2705467, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79f3e2705467, replyNumber=0, likeNumber=108, createdTime=2022-05-17, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79f3e2705467, moduleTitle=Lancet子刊：不明原因儿童急性肝炎或与新冠病毒超级抗原及腺病毒41F叠加相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=79f3e2705467)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623430, encodeId=5b8516234302a, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=allo-HSCT后供者细胞上的抗原表达缺失或下调了？, objectType=article, longId=727041, objectId=68b2e270414b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=68b2e270414b, replyNumber=0, likeNumber=113, createdTime=2022-05-17, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=68b2e270414b, moduleTitle=allo-HSCT后供者细胞上的抗原表达缺失或下调了？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=68b2e270414b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623441, encodeId=843016234418c, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=个性化新抗原肿瘤疫苗的研究进展, objectType=article, longId=726913, objectId=7840e269135b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7840e269135b, replyNumber=0, likeNumber=96, createdTime=2022-05-17, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7840e269135b, moduleTitle=个性化新抗原肿瘤疫苗的研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7840e269135b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623428, encodeId=d1911623428ea, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=AJH：针对 B 细胞成熟抗原的 CAR-T 细胞疗法对复发/难治性多发性骨髓瘤有效，包括体能状态不佳的病例, objectType=article, longId=726769, objectId=f014e26769c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f014e26769c3, replyNumber=0, likeNumber=93, createdTime=2022-05-14, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f014e26769c3, moduleTitle=AJH：针对 B 细胞成熟抗原的 CAR-T 细胞疗法对复发/难治性多发性骨髓瘤有效，包括体能状态不佳的病例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f014e26769c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623427, encodeId=8543162342e4f, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=博生吉靶向B7-H3嵌合抗原受体T细胞注射液获得美国FDA罕见儿科疾病（RPD）认定, objectType=article, longId=724805, objectId=f9ffe2480599, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9ffe2480599, replyNumber=0, likeNumber=96, createdTime=2022-04-24, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9ffe2480599, moduleTitle=博生吉靶向B7-H3嵌合抗原受体T细胞注射液获得美国FDA罕见儿科疾病（RPD）认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9ffe2480599)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623426, encodeId=59d9162342629, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=美国CDC新冠抗原检测指南编译, objectType=article, longId=724371, objectId=ae3fe243716a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae3fe243716a, replyNumber=0, likeNumber=82, createdTime=2022-04-17, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae3fe243716a, moduleTitle=美国CDC新冠抗原检测指南编译, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae3fe243716a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623425, encodeId=14ea1623425e3, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=昨日上海新增本土新冠肺炎确诊病例1015例、无症状感染者22609例，今起全市抗原检测（2022.04.09）, objectType=article, longId=723886, objectId=7fffe2388641, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7fffe2388641, replyNumber=0, likeNumber=97, createdTime=2022-04-10, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7fffe2388641, moduleTitle=昨日上海新增本土新冠肺炎确诊病例1015例、无症状感染者22609例，今起全市抗原检测（2022.04.09）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7fffe2388641)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623424, encodeId=29b01623424e4, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=JCI：北大人民医院申占龙团队揭示亚洲人特异性的IgG1记忆性B细胞抗原受体变异体对结直肠癌微环境中的作用机制, objectType=article, longId=723842, objectId=7473e23842f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7473e23842f1, replyNumber=0, likeNumber=107, createdTime=2022-04-10, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7473e23842f1, moduleTitle=JCI：北大人民医院申占龙团队揭示亚洲人特异性的IgG1记忆性B细胞抗原受体变异体对结直肠癌微环境中的作用机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7473e23842f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1623422, encodeId=8ea816234226f, content=<a href='/topic/show?id=62a655263e9' target=_blank style='color:#2F92EE;'>#抗原#</a>, objectTitle=上海：4月2日起，离沪人员须持“核酸+抗原”双阴性证明 | 上海疫情全新消息（2022.4.1）, objectType=article, longId=302152, objectId=124d30215286, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=124d30215286, replyNumber=0, likeNumber=110, createdTime=2022-04-02, rootId=0, userName=xiaoyeshuang, userId=f59b20519025, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=124d30215286, moduleTitle=上海：4月2日起，离沪人员须持“核酸+抗原”双阴性证明 | 上海疫情全新消息（2022.4.1）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=124d30215286)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

抗原

2020-05-29

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Nature：一类新型抗原呈递细胞在生命早期建立肠道免疫耐受

2022-09-14

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

J Autoimmun：磷酸酶控制细胞因子介导的半乳糖缺陷型IgA1（IgA肾病的主要自身抗原）过量产生

2022-09-03

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Clin Infect Dis：南非晚期HIV疾病队列中抗体免疫与隐球菌抗原血症和死亡率的关系

2022-08-31

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Cancer Cell：BioNTech新论文——肿瘤新抗原疫苗+化疗+PD-1，三管齐下治肺癌

2022-08-31

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Eur Urol：前列腺特异性膜抗原放射引导手术检测前列腺癌患者的淋巴结转移

2022-08-27

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Rh抗原分型出现双群的原因解析和案例分享

2022-08-24

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

JAMA netw open：人类白细胞抗原和其他位点单核苷酸变异与儿童霍奇金淋巴瘤的关系

2022-08-11

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

肿瘤抗原诱导的T细胞耗竭：免疫“热”肿瘤的大敌

2022-07-30

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Front Immunol：HBV感染肝癌患者接受PD-1抑制剂联合治疗时HBV DNA和乙肝表面抗原水平与肿瘤疗效、肝功能和免疫学指标的相关性

2022-06-29

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Eur Urol：前列腺特异性膜抗原放射引导进行挽救性淋巴结清扫治疗患者的肿瘤学结果

2022-06-28

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Exp Hematol：血清 B 细胞成熟抗原是未经治疗的慢性淋巴细胞白血病的独立预后标志物

2022-06-04

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

Lancet子刊：不明原因儿童急性肝炎或与新冠病毒超级抗原及腺病毒41F叠加相关

2022-05-17

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

allo-HSCT后供者细胞上的抗原表达缺失或下调了？

2022-05-17

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

个性化新抗原肿瘤疫苗的研究进展

2022-05-17

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

AJH：针对 B 细胞成熟抗原的 CAR-T 细胞疗法对复发/难治性多发性骨髓瘤有效，包括体能状态不佳的病例

2022-05-14

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

博生吉靶向B7-H3嵌合抗原受体T细胞注射液获得美国FDA罕见儿科疾病（RPD）认定

2022-04-24

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

美国CDC新冠抗原检测指南编译

2022-04-17

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

昨日上海新增本土新冠肺炎确诊病例1015例、无症状感染者22609例，今起全市抗原检测（2022.04.09）

2022-04-10

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

JCI：北大人民医院申占龙团队揭示亚洲人特异性的IgG1记忆性B细胞抗原受体变异体对结直肠癌微环境中的作用机制

2022-04-10

xiaoyeshuang (审核中...)

前往app查看评论内容

#抗原#

上海：4月2日起，离沪人员须持“核酸+抗原”双阴性证明 | 上海疫情全新消息（2022.4.1）

2022-04-02

科室
- - 订阅+
  - 更多科室
工具
服务